FDA warned Midwestern Pet Food over aflatoxin- and Salmonella-contaminated dog and cat food made under inadequate preventive controls.
What happened
After a Class I recall and consumer complaints of suspected mycotoxin poisoning, FDA and state officials inspected four Midwestern Pet Food facilities between December 31, 2020 and April 16, 2021. They found aflatoxin as high as 558 ppb in SPORTMiX dog and cat food and found that Salmonella-positive pet food lots were distributed. FDA also cited failures in hazard analysis and preventive controls across the OK, NY, IN, and IL plants.
What FDA found
Failed to properly implement its aflatoxin preventive control for incoming corn and corn products, and finished SPORTMiX pet food contained aflatoxin at 21.5 to 558 ppb.
21 CFR 507.34(a)(1)Distributed Salmonella-positive pet food lots after in-house and third-party testing confirmed positives, so its Salmonella control did not prevent adulterated product from reaching commerce.
21 CFR 507.34(a)(1)Did not identify or evaluate vomitoxin and fumonisin hazards in hazard analyses for incoming grains at the OK, IN, and IL facilities.
21 CFR 507.33(a)At the NY and IN facilities, did not verify the environmental pathogen preventive control through required environmental monitoring.
21 CFR 507.49(a)(3)Pet food containing aflatoxin above 20 ppb is adulterated because it may be fatal or injurious to pets.
FD&C Act section 402(a)(1) [21 U.S.C. § 342(a)(1)]Pet food was prepared, packed, or held under insanitary conditions that may have made it injurious to health.
FD&C Act section 402(a)(4) [21 U.S.C. § 342(a)(4)]
What FDA wants
FDA tells Midwestern Pet Food to investigate and correct the causes of the violations and prevent recurrence; the letter states no specific response deadline and warns that failure may lead to seizure or injunction.
Who should pay attention
- pet food brands that buy or co-manufacture dry pet food
- retailers and distributors of SPORTMiX and Earthborn products
- pet owners feeding dry dog or cat food
This is a summary. Read the original letter on fda.gov.